Annual Operating Expenses
$96.17 M
-$6.07 M-5.93%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual total operating expenses is $96.17 million, with the most recent change of -$6.07 million (-5.93%) on December 31, 2023.
- During the last 3 years, ABUS annual operating expenses has risen by +$31.99 million (+49.84%).
- ABUS annual operating expenses is now -5.93% below its all-time high of $102.24 million, reached on December 31, 2022.
Performance
ABUS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$18.81 M
-$4.29 M-18.56%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly total operating expenses is $18.81 million, with the most recent change of -$4.29 million (-18.56%) on September 30, 2024.
- Over the past year, ABUS quarterly operating expenses has dropped by -$1.91 million (-9.20%).
- ABUS quarterly operating expenses is now -52.06% below its all-time high of $39.23 million, reached on June 30, 2016.
Performance
ABUS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ABUS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | -9.2% |
| 3 y3 years | +49.8% | -30.8% |
| 5 y5 years | +26.4% | -30.8% |
ABUS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.9% | +16.4% | -33.2% | at low |
| 5 y | 5-year | -5.9% | +49.8% | -33.2% | +30.0% |
| alltime | all time | -5.9% | +600.6% | -52.1% | +151.2% |
Arbutus Biopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.81 M(-18.6%) |
| Jun 2024 | - | $23.10 M(+11.5%) |
| Mar 2024 | - | $20.71 M(-8.6%) |
| Dec 2023 | $96.17 M(-5.9%) | $22.66 M(-12.9%) |
| Sep 2023 | - | $26.01 M(+9.9%) |
| Jun 2023 | - | $23.67 M(-0.7%) |
| Mar 2023 | - | $23.83 M(-12.4%) |
| Dec 2022 | $102.24 M(+23.7%) | $27.20 M(+15.5%) |
| Sep 2022 | - | $23.55 M(-16.3%) |
| Jun 2022 | - | $28.14 M(+20.5%) |
| Mar 2022 | - | $23.35 M(-1.9%) |
| Dec 2021 | $82.64 M(+28.8%) | $23.81 M(+14.0%) |
| Sep 2021 | - | $20.89 M(+3.0%) |
| Jun 2021 | - | $20.28 M(+14.8%) |
| Mar 2021 | - | $17.66 M(-4.9%) |
| Dec 2020 | $64.18 M(-17.0%) | $18.56 M(+11.7%) |
| Sep 2020 | - | $16.62 M(+14.4%) |
| Jun 2020 | - | $14.53 M(+0.4%) |
| Mar 2020 | - | $14.47 M(-2.2%) |
| Dec 2019 | $77.36 M(+1.6%) | $14.80 M(-31.1%) |
| Sep 2019 | - | $21.49 M(+0.2%) |
| Jun 2019 | - | $21.43 M(+9.2%) |
| Mar 2019 | - | $19.63 M(+12.2%) |
| Dec 2018 | $76.12 M(-5.8%) | $17.49 M(-11.2%) |
| Sep 2018 | - | $19.69 M(-4.9%) |
| Jun 2018 | - | $20.71 M(+13.7%) |
| Mar 2018 | - | $18.22 M(-17.1%) |
| Dec 2017 | $80.83 M(-20.6%) | $21.98 M(+11.1%) |
| Sep 2017 | - | $19.79 M(-3.6%) |
| Jun 2017 | - | $20.52 M(+10.7%) |
| Mar 2017 | - | $18.53 M(-16.6%) |
| Dec 2016 | $101.78 M(+29.6%) | $22.22 M(+12.5%) |
| Sep 2016 | - | $19.75 M(-49.7%) |
| Jun 2016 | - | $39.23 M(+90.6%) |
| Mar 2016 | - | $20.58 M(-12.2%) |
| Dec 2015 | $78.53 M(+63.9%) | $23.43 M(-3.2%) |
| Sep 2015 | - | $24.21 M(+38.4%) |
| Jun 2015 | - | $17.50 M(+30.7%) |
| Mar 2015 | - | $13.39 M(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $47.92 M(+73.5%) | $15.10 M(+34.7%) |
| Sep 2014 | - | $11.21 M(-0.2%) |
| Jun 2014 | - | $11.23 M(+8.1%) |
| Mar 2014 | - | $10.39 M(+4.3%) |
| Dec 2013 | $27.62 M(-243.7%) | $9.96 M(+50.6%) |
| Sep 2013 | - | $6.61 M(+11.8%) |
| Jun 2013 | - | $5.92 M(+15.4%) |
| Mar 2013 | - | $5.13 M(-114.0%) |
| Dec 2012 | -$19.21 M(-169.8%) | -$36.71 M(-849.4%) |
| Sep 2012 | - | $4.90 M(-19.7%) |
| Jun 2012 | - | $6.10 M(-1.9%) |
| Mar 2012 | - | $6.21 M(-72.5%) |
| Dec 2011 | $27.51 M(-1.6%) | $22.62 M(+1505.6%) |
| Sep 2011 | - | $1.41 M(-25.6%) |
| Jun 2011 | - | $1.89 M(+3.3%) |
| Mar 2011 | - | $1.83 M(-89.8%) |
| Dec 2010 | $27.95 M(+469.2%) | $17.99 M(+142.8%) |
| Sep 2010 | - | $7.41 M(+458.0%) |
| Jun 2010 | - | $1.33 M(+9.8%) |
| Mar 2010 | - | $1.21 M(-111.0%) |
| Dec 2009 | $4.91 M(-72.7%) | -$10.96 M(-299.7%) |
| Sep 2009 | - | $5.49 M(+291.6%) |
| Jun 2009 | - | $1.40 M(+20.6%) |
| Mar 2009 | - | $1.16 M(-18.1%) |
| Dec 2008 | $17.98 M(+270.4%) | $1.42 M(-78.6%) |
| Sep 2008 | - | $6.63 M(-12.7%) |
| Jun 2008 | - | $7.60 M(+859.3%) |
| Mar 2008 | - | $792.40 K(-118.7%) |
| Dec 2007 | $4.85 M(-46.7%) | -$4.24 M(-203.3%) |
| Sep 2007 | - | $4.10 M(+56.8%) |
| Jun 2007 | - | $2.62 M |
| Dec 2006 | $9.10 M(-36.7%) | - |
| Dec 2005 | $14.38 M(-59.6%) | - |
| Dec 2004 | $35.55 M(-4.9%) | - |
| Dec 2003 | $37.38 M(+28.8%) | - |
| Dec 2002 | $29.03 M(+48.0%) | - |
| Dec 2001 | $19.61 M(+81.7%) | - |
| Dec 2000 | $10.79 M(+15.9%) | - |
| Dec 1999 | $9.31 M(-6.7%) | - |
| Dec 1998 | $9.98 M | - |
FAQ
- What is Arbutus Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for Arbutus Biopharma?
- What is Arbutus Biopharma annual operating expenses year-on-year change?
- What is Arbutus Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly operating expenses year-on-year change?
What is Arbutus Biopharma annual total operating expenses?
The current annual operating expenses of ABUS is $96.17 M
What is the all time high annual operating expenses for Arbutus Biopharma?
Arbutus Biopharma all-time high annual total operating expenses is $102.24 M
What is Arbutus Biopharma annual operating expenses year-on-year change?
Over the past year, ABUS annual total operating expenses has changed by -$6.07 M (-5.93%)
What is Arbutus Biopharma quarterly total operating expenses?
The current quarterly operating expenses of ABUS is $18.81 M
What is the all time high quarterly operating expenses for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly total operating expenses is $39.23 M
What is Arbutus Biopharma quarterly operating expenses year-on-year change?
Over the past year, ABUS quarterly total operating expenses has changed by -$1.91 M (-9.20%)